Basis: Latest reported fiscal year. Source: stored company filings and market data; unavailable inputs remain N/A.
The forward PE ratio is 36.14 as of Friday, July 31, 2026.
Forward PE Ratio (36.14) = Close Price ($326.72) / Consensus Forward EPS ($9.04)
FORWARD PE RATIO
36.14
SECTOR MEDIAN · HEALTHCARE
19.20
median of 68 covered companies
CURRENT VS SECTOR MEDIAN
+88.18%
vs the sector median at left
Bio-Rad Laboratories, Inc.
Market Cap
$8.83B
Forward PE Ratio
36.14
| NAME | MARKET CAP | FORWARD PE RATIO |
|---|---|---|
| Bio-Rad Laboratories, Inc. (BIO) | $8.83B | 36.14 |
| Oscar Health, Inc. (OSCR)vs › | $8.10B | 28.30 |
| Henry Schein, Inc. (HSIC)vs › | $9.70B | 15.93 |
| Universal Health Services, Inc. (UHS)vs › | $9.88B | 7.17 |
| Tempus AI, Inc. (TEM)vs › | $7.75B | N/A |
| Molina Healthcare, Inc. (MOH)vs › | $10.16B | N/A |
| Walgreens Boots Alliance, Inc. (WBA)vs › | $10.37B | 7.65 |
| Bio-Techne Corporation (TECH)vs › | $11.28B | 37.45 |
| Charles River Laboratories International, Inc. (CRL)vs › | $11.30B | 21.13 |
| Insulet Corp. (PODD)vs › | $11.48B | 25.56 |
Trailing P/E
53.8
reported TTM EPS
Forward P/E
36.1
consensus next-FY EPS
The gap between the two multiples is the consensus growth expectation: analysts' forward EPS of $9.04 implies +48.9% EPS growth vs the reported trailing $6.07.
At today's $326.72 close, each upcoming fiscal year's consensus EPS implies a different multiple — how quickly the price is "paid down" by expected earnings if the estimates hold.
PE Ratio = Share Price / Diluted EPS (TTM)
The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| Fiscal year end |
|---|
| Consensus EPS |
|---|
| Estimate range |
|---|
| Analysts |
|---|
| Implied P/E |
|---|
| 2026-12-31 | $9.04 | $8.75 – $9.23 | 2 | 36.1x |
| 2027-12-31 | $9.96 | $9.65 – $10.18 | 2 | 32.8x |
| 2028-12-31 | $11.15 | $10.79 – $11.38 | 1 | 29.3x |
Source: FMP analyst consensus estimates, refreshed with the daily precompute. "n/m" = the consensus EPS is not positive, so a multiple is undefined. There is no forward P/E history chart here because charting one would require the estimates as they stood in the past, which we do not store — see the trailing P/E history for how the realized multiple has moved.
